REUMUTH MARY (Chief Financial Officer) sold 53.5% of their position (33.20K shares) of KALA BIO, INC. on the open market
Open‑market sale worth $27.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/24/2025ACC: 0001710969-25-000003
Officer· Chief Financial Officer
Since Jan 2019
-33.20K
Net shares
Net seller
$27.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
33.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−32.23K
Price / share
$0.83
Trade value
$26.75K
% of position
51.9%
10/22/2025
62.10K→29.87K
Common Stock
Direct
Shares
−967.00
Price / share
$0.82
Trade value
$792.94
% of position
3.2%
10/23/2025
29.87K→28.91K
Total
Net shares
−33.20K
Net value
-$27.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/22/2025 | S · Sale | −32.23K | $0.83 | $26.75K | 51.9% | 62.10K | 29.87K |
| Common Stock Direct | 10/23/2025 | S · Sale | −967.00 | $0.82 | $792.94 | 3.2% | 29.87K | 28.91K |
| Total | −33.20K | -$27.54K | ||||||
Derivative Transactions0
No derivative transactions reported